Sign in

CIK 0001861123 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Eikon Therapeutics, Inc.

Sign in to watch
Ticker
EIKN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842807586
Phone
341-777-0566
Business address
230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
Open-market buys, last 90 days
$1,031,045
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,031,045. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Column Group IV GP, LP +$1.0M 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series B-1 Preferred Stock −282,317 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series B-1 Preferred Stock −3,048,192 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series C Preferred Stock −12,123 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series C Preferred Stock −6,878 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series C-1 Preferred Stock −501,219 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series C-1 Preferred Stock −284,392 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series D Preferred Stock −1,711,025 0
2026-02-04 Foresite Capital Management IV, LLC 10% owner Conversion · Series D Preferred Stock −3,422,051 0

Page 5 of 5 · 88 trades